Aftimos Philippe G - Institut Jules Bordet, Université Libre de Bruxelles;Institut Jules Bordet, Université Libre de Bruxelles

基本信息

浏览量：141

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 273 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PS17-02: Elacestrant vs standard-of-care in ER+/HER2- advanced or metastatic breast cancer (mBC) with ESR1 mutation: key biomarkers and clinical subgroup analyses from the phase 3 EMERALD trial

Aditya Bardia,Joyce O'Shaughnessy,Francois-Clement Bidard,Patrick Neven,José Ángel García-Sáenz,Philippe Aftimos,Javier Cortés,Janice Lu,Giulia Tonini, Kathy Puvana Theall, Alessandro Paoli,Virginia Kaklamani

Cancer Researchno. 9_Supplement (2024): PS17-02

引用0浏览0引用

290P Subtype-specific Prognostic Value of Lobular Histology in Patients with Early-Stage Breast Cancer: A Nationwide Population-Based Study

G. Nader Marta, L. Ameye,D. Martins Branco,R.F. Salgado, N. Van Damme, J. Verbeeck,P.G. Aftimos,L. Buisseret, M. Paesmans,C. Molinelli, M. Lambertini,K. Van Baelen, C. Desmedt, M. Piccart,E. de Azambuja

Annals of Oncology (2024)

引用0浏览0引用

Abstract PS17-04: Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches

Cancer Researchno. 9_Supplement (2024): PS17-04

引用0浏览0引用

Elacestrant Vs Standard-of-Care in ER+/HER2- Advanced or Metastatic Breast Cancer (mbc) with ESR1 Mutation: Key Biomarkers and Clinical Subgroup Analyses from the Phase 3 EMERALD Trial

Aditya Bardia,Joyce O'Shaughnessy, Francois-Clement Bidard,Patrick Neven, Jose Angel Garcia-Saenz,Philippe Aftimos,Javier Cortes,Janice Lu,Giulia Tonini, Kathy Puvana Theall,Alessandro Paoli,Virginia Kaklamani

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract PS09-04: The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: sub-analysis of the APHINITY trial

Evandro de Azambuja,Elisa Agostinetto, Faye Samy,Serena Di Cosimo,Philippe Aftimos,Noam Pondé,Daniel Eiger,Matteo Lambertini,David Cameron,Astrid Kiermaier,Andrew Bailey,Giuseppe Viale,Sherene Loi,Martine Piccart

Cancer Researchno. 9_Supplement (2024): PS09-04

引用0浏览0引用

Imlunestrant, an Oral Selective Estrogen Receptor Degrader (SERD), in Combination with Human Epidermal Growth Factor Receptor 2 (HER2) Directed Therapy, with or Without Abemaciclib, in Estrogen Receptor (ER) Positive, HER2 Positive Advanced Breast Cancer (abc): EMBER Phase 1a/1b Study

Manali A. Bhave,Komal L. Jhaveri,Peter A. Kaufman,Philippe Georges Aftimos,Janine Margaret Lombard,Kostandinos Sideras,Seock-Ah Im,Cynthia X. Ma,Kuo-Ting Lee,Sung-Bae Kim, Yujia Li,Eunice Yuen,Shawn T. Estrem,Bastien Nguyen, Francesca Bacchion,Roohi Ismail-Khan,Muralidhar Beeram,Joohyuk Sohn

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

The Benefit of Adjuvant Pertuzumab and Trastuzumab According to Estrogen Receptor and HER2 Expression: Sub-Analysis of the APHINITY Trial

Evandro de Azambuja,Elisa Agostinetto, Faye Samy, Serena Di Cosimo,Philippe Aftimos, Noam Ponde, Daniel Eiger, Matteo Lambertini,David Cameron,Astrid Kiermaier, Andrew Bailey,Giuseppe Viale,Sherene Loi, Martine Piccart

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

A Preoperative Window-of-opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-positive, HER2-negative Early Breast Cancer: Results from EMBER-2 Study

Patrick Neven, Nicole Stahl, Maria Vidal,Miguel Martín,Peter A Kaufman,Nadia Harbeck,Kelly K Hunt,Stacey Carter,Francois-Clement Bidard, Peter A Fasching,Philippe Aftimos,Duncan Wheatley,Erika Hamilton,Rebecca Aft,Swati Kulkarni,Peter Schmid,Manali Bhave,Roohi Ismail-Khan, Claudia Karacsonyi,Shawn T Estrem,Bastien Nguyen,Umut Ozbek, Eunice Yuen, Vanessa Rodrik-Outmezguine,Eva Ciruelos

Clinical cancer research an official journal of the American Association for Cancer Research (2024)

引用0浏览0WOS引用

Trastuzumab Deruxtecan in Patients with Solid Tumours Harbouring Specific Activating HER2 Mutations (Destiny-Pantumor01): an International, Phase 2 Study

Bob T. Li,Funda Meric-Bernstam,Aditya Bardia,Yoichi Naito,Salvatore Siena,Philippe Aftimos,Ian Anderson,Giuseppe Curigliano,Maria de Miguel, Maitri Kalra,Do-Youn Oh,Joon Oh Park,Sophie Postel-Vinay,Sun Young Rha,Taroh Satoh,Iben Spanggaard,Flavia Michelini, Ann Smith, Karime Kalil Machado,Cristina Saura

LANCET ONCOLOGYno. 6 (2024): 707-719

引用0浏览0WOS引用

Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches

Angel Guerrero-Zotano,Matteo Benelli,Alexandre Irrthum,David Cameron,Lorenzo Ferrando,Dario Romagnoli,Marta Paoli, Arnau Llinas, Maya Dadiani,Danai Fimereli,Mafalda Oliveira,Carmela Caballero, Thayane Crestani,Elisa Agostinetto, Diogo Martins-Branco,Florentine Hilbers, Einav Gal-Yam,Marija Balic,Fatima Cardoso, Jorge Reis-Filho,Christos Sotiriou,Giuseppe Curigliano, Barbro Linderholm,Evandro de Azambuja,Susan Knox, Cristina Rotaru,Eva Ciruelos,Nancy E. Davidson,Giuseppe Viale,Donatienne Taylor, Jean-Luc Canon,Lourdes Calvo,Joan Albanell,Marco Colleoni, Caroline Duhem,Nadia Harbeck, Catherine Herremans,Sibylle Loibl,Sandrine Marreaud, Elsemieke Scheepers, Alice Raimbault,Theodora Goulioti,Andrea Vingiani,Chiara Biagioni, Sebastian Vosberg,Gabriele Zoppoli, Jose Seoane, David Venet,Philippe Aftimos, Martine Piccart

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn